P1021: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE INTOLERANT TO RUXOLITINIB: AN OPEN-LABEL, SINGLE-ARM PHASE 2B STUDY

• Yi Zhang,
• Hu Zhou,
• Zhijian Xiao,
• Minghui Duan,
• Sujun Gao,
• Guangsheng He,
• Hongmei Jing,
• Junmin LI,
• Liangming MA,
• Huanling Zhu,
• Chunkang Chang,
• Xin Du,
• Mei Hong,
• Xin LI,
• Qingchi Liu,
• Wei Wang,
• Xu Na,
• Haiping Yang,
• Qingwei Zhao,
• Jie Jin

Affiliations

Yi Zhang

1 The First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Hu Zhou

2 The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Hemostasis and Thrombosis Diagnostic Engineering Research Center of Henan Province, Department of Hematology, Zhengzhou, China

Zhijian Xiao

3 Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Minghui Duan

4 Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Department of Hematology, Beijing, China

Sujun Gao

5 The First Hospital of Jilin University, Department of Hematology, Changchun, China

Guangsheng He

6 The First Affiliated Hospital of Nanjing Medical University, Jiangsu Provincial People’s Hospital, Key Laboratory of Hematology of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalize, Department of Hematology, Nanjing, China

Hongmei Jing

7 Peking University Third Hospital, Department of Hematology, Beijing, China

Junmin LI

8 Ruijin Hospital, Shanghai Jiaotong University Medical School, Department of Hematology, Shanghai, China

Liangming MA

9 Shanxi Bethune Hospital, The Third Hospital of Shanxi Medical University, Department of Hematology, Taiyuan, China

Huanling Zhu

10 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China

Chunkang Chang

11 Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Department of Hematology, Shanghai, China

Xin Du

12 Guangdong Provincial People’s Hospital, Department of Hematology, Guangzhou, China

Mei Hong

13 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Hematology, Wuhan, China

Xin LI

14 The Third Xiangya Hospital, Central South University, Department of Hematology, Changsha, China

Qingchi Liu

15 The First Hospital of Hebei Medical University, Department of Hematology, Shijiazhuang, China

Wei Wang

16 The Affiliated Hospital of Qingdao University, Department of Hematology, Qingdao, China

Xu Na

17 Nanfang Hospital, Southern Medical University, Department of Hematology, Guangzhou, China

Haiping Yang

18 The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Department of Hematology, Luoyang, China

Qingwei Zhao

19 State Key Laboratory for diagnosis and treatment of infectious diseases, Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Jie Jin

1 The First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China